StockIQ.techZymeworks Inc. (ZYME) Stock Analysis
Free AI-powered analysis and research for Zymeworks Inc. stock
Sector: Healthcare
Full ZYME report
Zymeworks Inc. (ZYME) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze ZYME Now →📰 Latest Update
Zymeworks (ZYME) Gains Fresh Backing On Trial Data And Roche Deal
Wed, November 4, 2026 at 4:33 AM UTC 4 min read
Zymeworks (ZYME) has gained attention following two significant announcements: new Phase 1 data for its ZW191 ovarian cancer treatment and a licensing deal with Roche for ZW209. The company's share price has seen strong returns, with a 19.8% increase over the past month and a 65.9% rise over the past year. However, the article notes concerns about the stock's high valuation relative to its peers, suggesting that any setbacks could impact investor sentiment significantly.